Difference between revisions of "Team:Calgary/MedalRequirements"
| Line 195: | Line 195: | ||
</h5> | </h5> | ||
<p> | <p> | ||
| − | We have created a parts collection (BBa_K2605000 to BBa_K2605004 and BBa_K2605009) for use in targeted gene integration and maintenance in eukaryotic cells. Each part in this collection has been verified with restriction enzymes and sequence confirmed for validity. See our <a href="https://2018.igem.org/Team:Calgary/Parts"> | + | We have created a parts collection (BBa_K2605000 to BBa_K2605004 and BBa_K2605009) for use in targeted gene integration and maintenance in eukaryotic cells. Each part in this collection has been verified with restriction enzymes and sequence confirmed for validity. See our <a href="https://2018.igem.org/Team:Calgary/Parts">Parts</a> page for more information. |
</p> | </p> | ||
</div> | </div> | ||
| Line 211: | Line 211: | ||
</h5> | </h5> | ||
<p> | <p> | ||
| − | Our team carefully considered the social impact of our actions by identifying and discussing potential ethical issues with our mentors. Additionally, we emphasized outreach to researchers, students, and adults in the community to engage a discussion about synthetic biology. See our <a href="https://2018.igem.org/Team:Calgary/Human_Practices"> | + | Our team carefully considered the social impact of our actions by identifying and discussing potential ethical issues with our mentors. Additionally, we emphasized outreach to researchers, students, and adults in the community to engage a discussion about synthetic biology. See our <a href="https://2018.igem.org/Team:Calgary/Human_Practices">Human Practices</a> page for more details. |
</p> | </p> | ||
</p> | </p> | ||
| Line 226: | Line 226: | ||
</h5> | </h5> | ||
<p> | <p> | ||
| − | The integration of expert feedback played a major role in informing a pivot from gene therapy towards a research-oriented gene integration platform. Discourse involving bio-ethicists, researchers, university faculty, and spiritual thought leaders all contributed to the re-working of our initial plans to create a project that better suits the community's needs. See our <a href="https://2018.igem.org/Team:Calgary/Human_Practices"> | + | The integration of expert feedback played a major role in informing a pivot from gene therapy towards a research-oriented gene integration platform. Discourse involving bio-ethicists, researchers, university faculty, and spiritual thought leaders all contributed to the re-working of our initial plans to create a project that better suits the community's needs. See our <a href="https://2018.igem.org/Team:Calgary/Human_Practices">Human Practices</a> page for more details. |
</p> | </p> | ||
</div> | </div> | ||
| Line 234: | Line 234: | ||
</h5> | </h5> | ||
<p> | <p> | ||
| − | Part BBa_K747096 was improved by the addition of a SalI restriction site upstream of the promotor. This new part, BBa_K2605001, is built to be compatible with our Multiple Cloning Site. See our <a href="https://2018.igem.org/Team:Calgary/Improve"> | + | Part BBa_K747096 was improved by the addition of a SalI restriction site upstream of the promotor. This new part, BBa_K2605001, is built to be compatible with our Multiple Cloning Site. See our <a href="https://2018.igem.org/Team:Calgary/Improve">Improved Part</a> page for more details. |
</p> | </p> | ||
</div> | </div> | ||
Revision as of 21:43, 17 October 2018
MEDAL REQUIREMENTS
BRONZE
Registration and Attendance
The team has registered for and will be attending the 2018 Giant Jamboree in Boston from October 24th-28th.
Competition Deliverables
- Wiki (In Progress)
- Poster (In Progress)
- Presentation (In Progress)
- Judging Form (In Progress)
Attributions
Our project would not have been possible without the hard work of every member, mentor, and advisor. Check out our Attributions page for detailed information concerning the contributions of team members, mentors, and advisors.
Characterization / Contribution
Our InterLab page shows how our team participated in the InterLab study this year.
SILVER
Validated Part / Contribution
We have created a parts collection (BBa_K2605000 to BBa_K2605004 and BBa_K2605009) for use in targeted gene integration and maintenance in eukaryotic cells. Each part in this collection has been verified with restriction enzymes and sequence confirmed for validity. See our Parts page for more information.
Collaboration
In addition to hosting the 2018 aGEM meetup, we worked with the NDC-HighRiverAB iGEM team, Queens Canada iGEM team, and the Lethbridge iGEM team on collaborations. See our Collaborations page for more details.
Human Practices
Our team carefully considered the social impact of our actions by identifying and discussing potential ethical issues with our mentors. Additionally, we emphasized outreach to researchers, students, and adults in the community to engage a discussion about synthetic biology. See our Human Practices page for more details.
GOLD
Integrated Human Practices
The integration of expert feedback played a major role in informing a pivot from gene therapy towards a research-oriented gene integration platform. Discourse involving bio-ethicists, researchers, university faculty, and spiritual thought leaders all contributed to the re-working of our initial plans to create a project that better suits the community's needs. See our Human Practices page for more details.
Improve a Previous Part / Project
Part BBa_K747096 was improved by the addition of a SalI restriction site upstream of the promotor. This new part, BBa_K2605001, is built to be compatible with our Multiple Cloning Site. See our Improved Part page for more details.